|
Attention Business Editors
CRH Medical provides significant new patient inquiries to physicians
VANCOUVER, June 15 /CNW/ - CRH Medical Corporation (CRM:TSX-V) announced
today that its innovative marketing program is providing significant new
patient inquiries to physicians listed on the Company's website who have been
trained in the use of the Company's proprietary technology and methods known
as the CRH O'Regan System(TM).
The Company's marketing program utilizes leading-edge search engine
marketing and optimization strategies to attract hemorrhoid sufferers to its
website, www.crhsystems.com. The website receives more than 17,000 first time
visitors per month providing in excess of 1,000 new patient inquiries to the
more than 295 participating physicians in 30 states. Access to hemorrhoid
banding treatments using the CRH O'Regan System(TM) has dramatically increased
since this time last year when the Company had 130 participating physicians.
Commenting on his experience working with CRH, Dr. Harry Sarles from
Dallas, TX said, "CRH is the only medical products company that provides a
comprehensive program which includes training, technology and new patients. We
are very pleased with the patient outcomes and the number of new patients we
have received as a result of our relationship with CRH Medical Corporation."
About CRH Medical Corporation:
CRH Medical Corporation specializes in the treatment of hemorrhoids
utilizing its proven treatment protocol and patented proprietary technology.
CRH's single use, disposable, hemorrhoid technology is safe and highly
effective in treating hemorrhoid grades I - IV. CRH Medical employs two
commercialization strategies: First, it operates Centers for Colorectal Health
facilities in the United States specializing in the treatment of hemorrhoids
and fissures, and colon cancer screening. In addition CRH distributes its
hemorrhoid banding technology, treatment protocols, operational and marketing
expertise as a complete, "turn key" package directly to its partner
physicians. The Company's goal is to establish the CRH hemorrhoid technology
as the standard for hemorrhoid treatment.
The information in this news release contains so-called "forward-looking"
statements. These include statements regarding CRH Medical expectations,
beliefs, intentions or strategies for the future, which may be indicated by
words or phrases such as "anticipate", "expect", "intend", "plan", "will", "we
believe", "CRH Medical believes", "management believes" and similar language.
All forward-looking statements are based on CRH Medical current expectations
and are subject to risks and uncertainties and to assumptions made.
For further information call Dean Linden, Corporate Communications, CRH
Medical Corporation at 604.633.1440 or ir@crhmedcorp.com. Additional
information may also be found by visiting the Company's website at
www.crhmedcorp.com or the SEDAR website at www.sedar.com.
The TSX Venture Exchange does not accept responsibility for the adequacy
or accuracy of this release.
-30-
/For further information: Investor Contact: Dean Linden, 604.633.1440/
|
NEWS RELEASES